Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
2.440
+0.280 (12.96%)
At close: Jan 13, 2026, 4:00 PM EST
2.400
-0.040 (-1.64%)
After-hours: Jan 13, 2026, 7:56 PM EST
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $3.66 million as of January 13, 2026. Its market cap has decreased by -51.46% in one year.
Market Cap
3.66M
Enterprise Value
-108.44K
1-Year Change
-51.46%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $3.66M, a decrease of -86.01%. That is a compound annual growth rate of -35.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 3.24M | 19.34% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
| Aug 16, 2021 | 26.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 954.33B |
| Johnson & Johnson | 500.80B |
| AbbVie | 386.79B |
| UnitedHealth Group | 306.45B |
| AstraZeneca | 295.57B |
| Novartis AG | 272.98B |
| Merck & Co. | 271.96B |
| Novo Nordisk | 263.81B |